Danaher (DHR) Form 3: Jonathan Leiken reports no holdings

Jonathan Leiken, identified as SVP - General Counsel of Danaher Corporation (DHR), submitted an initial Form 3 reporting the event dated 08/25/2025.

Rhea-AI Filing Summary

Jonathan Leiken, identified as SVP - General Counsel of Danaher Corporation (DHR), submitted an initial Form 3 reporting the event dated 08/25/2025. The filing states that no securities are beneficially owned by Mr. Leiken (listed as 0 shares) and includes an exhibit referencing a Power of Attorney (Exhibit 24). The form was signed on behalf of Mr. Leiken by an attorney‑in‑fact, James F. O'Reilly, on 08/27/2025. This is an initial insider disclosure with no reported direct or derivative holdings.

Positive

• Timely initial disclosure filed for an officer with event date 08/25/2025
• Clear statement of zero beneficial ownership (listed as 0 shares), removing ambiguity about insider holdings

Negative

• No reported ownership means the insider currently holds 0 shares or derivatives
• Signed by attorney‑in‑fact rather than the reporting person (may merit direct signature later)

Insights

Corporate Governance Specialist

Initial insider filing shows no reported holdings for a senior officer.

The Form 3 formally discloses that Jonathan Leiken, serving as SVP - General Counsel, currently holds 0 shares or derivative positions in Danaher (DHR) as of the 08/25/2025 event date.

Filing by an attorney‑in‑fact and inclusion of Exhibit 24 (Power of Attorney) are procedural details confirming authorized signature rather than signaling a transaction.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Leiken Jonathan

Role SVP- General Counsel

Type	Security	Shares	Price	Value
holding	No securities are beneficially owned	--	--	--

Holdings After Transaction: No securities are beneficially owned — 0 shares (Direct)

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Danaher's (DHR) Form 3 filed by Jonathan Leiken report?

The Form 3 reports that Jonathan Leiken (SVP - General Counsel) beneficially owns 0 shares of Danaher (DHR) as of the event date 08/25/2025.

When is the event date listed on the Form 3 for DHR?

The event date reported on the Form 3 is 08/25/2025.

Who signed the Form 3 for Jonathan Leiken?

The form was signed on behalf of Jonathan Leiken by attorney‑in‑fact James F. O'Reilly on 08/27/2025.

Does the filing show any derivative securities for Jonathan Leiken?

No. Table II for derivative securities is blank and the filing states no derivative securities are owned.

Is there an exhibit attached to the Form 3?

Yes. The filing lists Exhibit 24, which is a Power of Attorney.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/27/2025 - 05:01 PM Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Leiken Jonathan

(Last) (First) (Middle)

2200 PENNSYLVANIA AVE NW

SUITE 800W

(Street)

WASHINGTON DC 20037

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
08/25/2025

3. Issuer Name and Ticker or Trading Symbol
DANAHER CORP /DE/ [ DHR ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP- General Counsel

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
No securities are beneficially owned	0	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit List: Exhibit 24- Power of Attorney

	/s/ James F. O'Reilly, attorney-in-fact for Jonathan Leiken	08/27/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.